Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DB25FPRQ2
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $98,899
Award facts
- Contract value 100% obligated
- $98,898.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $98,898.60 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for ENTYVIO 300 mg vials, with an ultimate completion date of October 17, 2025. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its Park Ridge location. This award was made without a set-aside designation, allowing the vendor to compete on an open basis despite its small business status.
This delivery order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026. The parent contract, executed under the DLA's SPE2DB program, enables the agency to procure a comprehensive range of pharmaceutical products supporting medical supply needs across Department of Defense healthcare facilities worldwide. ENTYVIO, a biologic medication used to treat inflammatory bowel disease, represents one of the specialized pharmaceutical products within the broader portfolio of branded drugs, generics, biologics, and medical consumables that DMS Pharmaceutical Group supplies to military and federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FPRQ2?
SPE2DB25FPRQ2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 25, 2025.
How much is contract SPE2DB25FPRQ2 worth?
The government has obligated $98,899 on SPE2DB25FPRQ2.
Is contract SPE2DB25FPRQ2 an order under another contract?
Yes. SPE2DB25FPRQ2 is a delivery order under SPE2DB20D9127, an indefinite delivery contract.
Was contract SPE2DB25FPRQ2 competed?
The extent of competition for SPE2DB25FPRQ2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award